Drug Combo Wins OK as First Line in Kidney Cancer

(MedPage Today) -- As shown in Checkmate 214 study, ipilimumab + nivolumab improve survival
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news